What Every Clinical Research Associate Wants to Know About Risk-Based Monitoring
The question of whether or not the role of the clinical research associate (CRA) will become obsolete has been coming up in many industry discussions. Such was the case at the Drug Information Association (DIA) Risk-Based Monitoring (RBM) Symposium. In this video, presenters Rita Purvis, Dermot Kenny and Marcus Thornton share their thoughts on the topic.
Guest bloggers: *Rita Purvis, Vice President, Clinical Operations, inVentiv Health Clinical *Dermot Kenny, EVP Global Clinical & Data Operations, Clinical Research Services, ICON *Marcus Thornton, Senior Director, Medidata Solutions Additional videos in this series: